Correlation Between Unity Biotechnology and Anebulo Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Unity Biotechnology and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unity Biotechnology and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unity Biotechnology and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Unity Biotechnology and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unity Biotechnology with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unity Biotechnology and Anebulo Pharmaceuticals.

Diversification Opportunities for Unity Biotechnology and Anebulo Pharmaceuticals

0.03

Correlation Coefficient

Unity Biotechnology  Anebulo Pharmaceuticals

Significant diversification

The 3 months correlation between Unity and Anebulo is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Unity Biotechnology and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Unity Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unity Biotechnology are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Unity Biotechnology i.e., Unity Biotechnology and Anebulo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Unity Biotechnology and Anebulo Pharmaceuticals

Considering the 90-day investment horizon Unity Biotechnology is expected to generate 1.53 times more return on investment than Anebulo Pharmaceuticals. However, Unity Biotechnology is 1.53 times more volatile than Anebulo Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest  96.00  in Unity Biotechnology on December 28, 2024 and sell it today you would earn a total of  18.00  from holding Unity Biotechnology or generate 18.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Unity Biotechnology  vs.  Anebulo Pharmaceuticals

Unity Biotechnology

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Unity Biotechnology are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent fundamental drivers, Unity Biotechnology showed solid returns over the last few months and may actually be approaching a breakup point.

Anebulo Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Unity Biotechnology and Anebulo Pharmaceuticals

The main advantage of trading using opposite Unity Biotechnology and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unity Biotechnology position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.

The idea behind Unity Biotechnology and Anebulo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.